<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand (TRAIL) induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a variety of transformed cell lines, but generally spares most <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Transduction by an adenoviral vector expressing human TRAIL cDNA (Ad.TRAIL-GFP) resulted in both direct <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell killing as well as a potent bystander effect through presentation of TRAIL by transduced <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Administration of Ad.TRAIL-GFP significantly prolonged survival of mice harboring either intracerebral <z:hpo ids='HP_0100843'>glioblastomas</z:hpo> or <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo>-induced <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Additionally, TRAIL induced prolonged transgene expression in <z:mpath ids='MPATH_458'>normal</z:mpath> tissue, presumably as a result of diminished immune-mediated destruction of vector-transduced cells </plain></SENT>
<SENT sid="4" pm="."><plain>Taken together, these data suggest that vector-mediated transduction of TRAIL may represent an effective strategy for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> gene therapy </plain></SENT>
</text></document>